doi: 10.58347/tml.2024.1702a.
Sotatercept (Winrevair) for pulmonary arterial hypertension
- PMID: 38696310
- DOI: 10.58347/tml.2024.1702a
Item in Clipboard
Sotatercept (Winrevair) for pulmonary arterial hypertension
Med Lett Drugs Ther.
.
No abstract available
Keywords: Adcirca; Adempas; Alyq; Flolan; Letairis; Liqrev; Opsumit; Opsynvi; Orenitram; Remodulin; Revatio; Tadliq; Tracleer; Tyvaso; Uptravi; Veletri; Ventavis; Winrevair; adverse effects; ambrisentan; bosentan; dosage; efficacy; epoprostenol; iloprost; lactation; macitentan; pregnancy; pulmonary arterial hypertension; riociguat; safety; selexipag; sildenafil; sotatercept; tadalafil; treprostinil.
Similar articles
-
Sotatercept: New drug on the horizon of pulmonary hypertension.Vascul Pharmacol. 2024 Dec;157:107442. doi: 10.1016/j.vph.2024.107442. Epub 2024 Nov 19. Vascul Pharmacol. 2024. PMID: 39571875 Review.
-
Prevalence of pulmonary arterial hypertension in the Camerino area of central Italy and savings resulting from generic bosentan.Eur J Hosp Pharm. 2020 Mar;27(2):100-102. doi: 10.1136/ejhpharm-2018-001660. Epub 2018 Oct 24. Eur J Hosp Pharm. 2020. PMID: 32133136 Free PMC article.
-
Sotatercept in pulmonary arterial hypertension: something different or more of the same?Nat Cardiovasc Res. 2023 Jun;2(6):487-488. doi: 10.1038/s44161-023-00283-1. Nat Cardiovasc Res. 2023. PMID: 39195879 No abstract available.
-
Sotatercept: First Approval.Drugs. 2024 Jul;84(7):857-862. doi: 10.1007/s40265-024-02058-9. Epub 2024 Jun 21. Drugs. 2024. PMID: 38904927 Review.
-
Ambrisentan (Letairis) and tadalafil (Adcirca) for pulmonary arterial hypertension.Med Lett Drugs Ther. 2016 Jan 4;58(1485):2-4. Med Lett Drugs Ther. 2016. PMID: 26714240 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
